You can help expand this article with text translated from the corresponding article in French. (May 2011) Click [show] for important translation instructions.
View a machine-translated version of the French article.
Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing French Wikipedia article at [[:fr:Ernest Fourneau]]; see its history for attribution.
You may also add the template {{Translated|fr|Ernest Fourneau}} to the talk page.
For more guidance, see Wikipedia:Translation.
Ernest Fourneau
Portrait of Ernest Fourneau by his son Jean-Claude Fourneau
Born
(1872-10-04)4 October 1872
Biarritz, France
Died
5 August 1949(1949-08-05) (aged 76)
Ascain, France
Nationality
French
Alma mater
École de pharmacie de Paris
Awards
Prix Jecker, of the Académie des Sciences (1919 and 1931)
Scientific career
Fields
Chemistry, Pharmacology
Institutions
Pasteur Institute
Notable students
Thérèse Tréfouël, Jacques Tréfouël
Notes
Son-in-law of Paul Segond Brother-in-law of Marc Tiffeneau Father of Jean-Claude Fourneau
Ernest Fourneau (4 October 1872 – 5 August 1949) was a French pharmacist who graduated in 1898 for the Paris university specialist in medicinal chemistry and pharmacology. He played a major role in the discovery of synthetic local anesthetics such as amylocaine, as well as in the synthesis of suramin. He authored more than two hundred scholarly works, and has been described as having "helped to establish the fundamental laws of chemotherapy that have saved so many human lives".[1][2]
Fourneau was a pupil of Friedel and Moureu, and studied in the German laboratories of Ludwig Gattermann in Heidelberg, Hermann Emil Fischer in Berlin and Richard Willstätter in Munich.
He headed the research laboratory of Poulenc Frères in Ivry-sur-Seine from 1903 to 1911.
One of the products was a synthetic local anesthetic that was named Stovaine (amylocaine).
This was a pun on the English translation of "fourneau" as "stove".[3] (The same pun was used in the brand name of the drug acetarsol, Stovarsol.)
Other important medicines were antipyretics.[4]
In 1910 Fourneau accepted the directorship of the Pasteur Institute's medical chemistry section, with the condition that he maintained his ties with Poulenc Frères.[3] He recruited Germaine Benoit to work in the Institute as a new graduate.[5]
He was a member of the Académie Nationale de Médecine.
^"Fourneau, Ernest". Complete Dictionary of Scientific Biography, 2008.
^Henry, T. A., "Ernest Fourneau". 1872–1949. J. Chem. Soc., 1952, pp. 261–272.
ErnestFourneau (4 October 1872 – 5 August 1949) was a French pharmacist who graduated in 1898 for the Paris university specialist in medicinal chemistry...
Fourneau is a French surname. Notable people with the surname include: ErnestFourneau (1872–1949), French medicinal chemist Jean-Claude Fourneau (1907–1981)...
anesthetic. It was synthesized and patented under the name Stovaine by ErnestFourneau at the Pasteur Institute in 1903. It was used mostly in spinal anesthesia...
original on 14 May 2014. Retrieved 18 May 2014. Jean-Pierre Fourneau, « ErnestFourneau, fondateur de la chimie thérapeutique française : Feuillets d'album »...
commercial reasons, but it was elucidated and published in 1924 by ErnestFourneau and his team at the Pasteur Institute. It is on the World Health Organization's...
simplest peptide. The compound was first synthesized by Emil Fischer and ErnestFourneau in 1901 by boiling 2,5-diketopiperazine (glycine anhydride) with hydrochloric...
INN for diacetyldapsone. It was synthesized and developed in 1937 by ErnestFourneau and his team in the pharmaceutical chemistry laboratory of Pasteur...
who along with Federico Nitti and Daniel Bovet in the laboratory of ErnestFourneau at the Pasteur Institute, determined sulfanilamide as the active form...
anti-infective drug. It was first discovered in 1921 at Pasteur Institute by ErnestFourneau, and sold under the brand name Stovarsol. It has been given in the...
Pasteur Institute (1935), then with that of dapsone independently by ErnestFourneau in France and Gladwin Buttle in the United Kingdom. The spread of drug-resistant...
within classes. The first H1-antihistamine discovered was piperoxan, by ErnestFourneau and Daniel Bovet (1933) in their efforts to develop a guinea pig animal...
early 1930s by Daniel Bovet and ErnestFourneau at the Pasteur Institute in France. Formerly investigated by Fourneau as an α-adrenergic-blocking agent...
between German and French researchers—notably those in the laboratory of ErnestFourneau at the Pasteur Institute in Paris—both for income and credit for work...
Liberato Pinto, 78th prime minister of Portugal (b. 1880) August 5 – ErnestFourneau, French chemist, pharmacologist (b. 1872) August 9 Gustavus M. Blech...
discovered by Eugène-Anatole Demarçay. Emil Fischer, in collaboration with ErnestFourneau, synthesizes the dipeptide, glycylglycine, and also publishes his work...
Campbell divides the cytoarchitecture of the human brain into 14 areas. ErnestFourneau synthesizes and patents Amylocaine, the first synthetic local anesthetic...
Thérèse Tréfouël, Daniel Bovet and Federico Nitti, in the laboratory of ErnestFourneau at the Pasteur Institute in Paris, discover that sulfanilamide is the...
working at the Pasteur Institute in Paris in the laboratory of Dr. ErnestFourneau, Jacques and Thérèse Tréfouël, Dr. Daniel Bovet and Federico Nitti...
as an assistant in the medicinal chemistry laboratory directed by ErnestFourneau. Ten years later, in 1934, she received the Prix Louis from the Académie...
the first commercially available; and in November a team directed by ErnestFourneau at the Pasteur Institute identify sulfanilamide as the active component...
Global Information
